NEW YORK--(BUSINESS WIRE)--Please replace the release with the following corrected version due to multiple revisions.
The corrected release reads:
AMERICORD ANNOUNCES THE APPOINTMENT OF DR. AASAWARI BAPAT AS ADVISOR, GLOBAL STEM CELL PRODUCT DEVELOPMENT
Americord, the fastest growing cord blood bank in the country, and a leader in the advancement of umbilical cord blood, cord tissue, and placenta tissue banking, has appointed Dr. Aasawari Bapat as Advisor, Global Stem Cell Product Development.
Dr. Bapat is an expert in the field of stem cell banking, transplants, and transfusions and an International Ambassador for the American Association of Blood Banking (AABB). She has over 15 years of experience in quality management, regulatory affairs, and lab accreditations for cord blood and adult stem cell banks, hospitals, and medical labs.
Throughout her career, Dr. Bapat has been instrumental in the successful start-up, accreditation, and management of cord blood banks in US, Australia, Middle East, Southeast Asia and India. She is trained in all the leading cord blood banking industry standards, including AABB, ISO, CAP, JCI, AABB, FACT, FDA, OSHA, and MOH.
“We are thrilled to have Dr. Bapat join the Americord team as our Advisor, Global Stem Cell Product Development,” commented Martin Smithmyer, CEO of Americord. “As we continue to grow, her expertise will be invaluable in ensuring we operate to the highest quality standards and deliver the best possible outcomes for our clients.”
Prior to joining Americord, Dr. Bapat served as Director of Quality and Regulatory Affairs for InfoHealth Global in Dubai, UAE, an international leader in organizational accreditation, global regulatory compliance, and quality management services for cellular based treatment programs and storage facilities. She holds an MD in Clinical Pathology and Bacteriology.
About Americord Registry (“Americord”)
Americord Registry is a leader in the advancement of umbilical cord blood, cord tissue and placenta tissue banking. Americord collects, processes, and stores newborn stem cells from umbilical cord blood for future medical or therapeutic use, including the treatment of more than 80 blood diseases such as sickle cell anemia and leukemia. Founded in 2008, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is CLIA Certified, accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Americord is headquartered in New York, NY. For more information, visit www.americordblood.com.